Koen Sintnicolaas

Koen Sintnicolaas is a Business Development Director, focusing on EQT’s Early Stage Healthcare strategies. He has held this position since 2022, when LSP joined forces with EQT and was renamed EQT Life Sciences.

Prior to his current role, Koen was part of the Finance team at LSP from 2016 to 2022, where he contributed to a broad range of strategic initiatives. His experience includes serving as CFO of European Biotech Acquisition Corp., a Nasdaq-listed company. Prior to LSP, Koen was a Business Controller at Fetim Group in Amsterdam and Finance Intern at Heineken in Congo.

Koen holds an MSc in Financial Economics from Erasmus University Rotterdam and a postgraduate degree in Business Analytics & Data Sciences from Vrije Universiteit Amsterdam.